We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Commentary · July 17, 2020

Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Cancer Patients Undergoing Hormone Deprivation Therapies

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies
J. Clin. Oncol 2020 Jun 30;[EPub Ahead of Print], A Dalla Volta, G Mazziotti, F Maffezzoni, S Grisanti, C Palumbo, R Pedersini, R Maroldi, A Berruti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading